KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) EBITDA Margin (2017 - 2025)

Historic EBITDA Margin for Moderna (MRNA) over the last 9 years, with Q3 2025 value amounting to 25.59%.

  • Moderna's EBITDA Margin fell 218300.0% to 25.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 155.15%, marking a year-over-year decrease of 1014600.0%. This contributed to the annual value of 121.91% for FY2024, which is 600100.0% down from last year.
  • Moderna's EBITDA Margin amounted to 25.59% in Q3 2025, which was down 218300.0% from 638.73% recorded in Q2 2025.
  • In the past 5 years, Moderna's EBITDA Margin ranged from a high of 75.02% in Q4 2021 and a low of 972.22% during Q1 2025
  • Its 5-year average for EBITDA Margin is 184.45%, with a median of 3.76% in 2024.
  • In the last 5 years, Moderna's EBITDA Margin skyrocketed by 17028600bps in 2021 and then crashed by -7384300bps in 2024.
  • Over the past 5 years, Moderna's EBITDA Margin (Quarter) stood at 75.02% in 2021, then crashed by -59bps to 31.08% in 2022, then plummeted by -99bps to 0.21% in 2023, then tumbled by -60530bps to 128.99% in 2024, then soared by 80bps to 25.59% in 2025.
  • Its last three reported values are 25.59% in Q3 2025, 638.73% for Q2 2025, and 972.22% during Q1 2025.